Retrieve available abstracts of 32 articles: HTML format
Single Articles
September 2025
REINA-GONZALEZ P, Ay M, Langley M, Plunk E, et al Neurotoxicants driving glial aging: role of astrocytic aging in non-cell
autonomous neurodegeneration.
Toxicol Sci. 2025;207:20-28. PubMedAbstract available
June 2025
POOLE LG, Wei Z, Schulte A, Cline HM, et al Kupffer cell expression of macrophage receptor with collagenous structure
modulates macrophage gene induction and limits acute liver injury.
Toxicol Sci. 2025;205:417-427. PubMedAbstract available
LIU X, Wang K, Zhang X, Qi J, et al Gallic acid relieved bortezomib-induced peripheral neurotoxicity by restoring
Schwann cell lysosomal activity.
Toxicol Sci. 2025;205:297-309. PubMedAbstract available
ALI NA, Kennon-McGill S, Parker LD, James LP, et al NAPQI is absent in the mouse brain after sub-hepatotoxic and hepatotoxic doses of
acetaminophen.
Toxicol Sci. 2025;205:274-278. PubMedAbstract available
NEWELL AJ, Patisaul HB Modeling the developing nervous system: a neuroscience perspective on the use of
new approach methodologies in developmental neurotoxicity testing.
Toxicol Sci. 2025;205:245-273. PubMedAbstract available
May 2025
SANCHEZ-GUERRERO G, Umbaugh DS, Smith SH, Akakpo JY, et al Mixed lineage kinase domain-like protein deficiency exacerbates early injury in a
mouse model of acetaminophen hepatotoxicity.
Toxicol Sci. 2025;205:220-232. PubMedAbstract available
BEAMISH CR, Becker J, Tam LM, Love T, et al Transcriptomic analysis identifies muscle-specific mitochondrial and vesicular
transport genes as methylmercury toxicity targets in a Drosophila model of
congenital Minamata disease.
Toxicol Sci. 2025;205:106-123. PubMedAbstract available
April 2025
BAJAJ P, Brennan RJ, Laurent S, Sauzeat S, et al Transcriptomic analysis in liver spheroids identifies a dog-specific mechanism of
hepatotoxicity for amcenestrant.
Toxicol Sci. 2025;204:228-241. PubMedAbstract available
PANNALA VR, Hari A, AbdulHameed MDM, Balik-Meisner MR, et al Quantifying liver-toxic responses from dose-dependent chemical exposures using a
rat genome-scale metabolic model.
Toxicol Sci. 2025;204:154-168. PubMedAbstract available
SHINOZAWA T, Miyamoto K, Baker KS, Faber SC, et al TAK-994 mechanistic investigation into drug-induced liver injury.
Toxicol Sci. 2025;204:143-153. PubMedAbstract available
January 2025
LIVOTI LA, Sison-Young R, Reddyhoff D, Fisher CP, et al Limitations of acetaminophen as a reference hepatotoxin for the evaluation of in
vitro liver models.
Toxicol Sci. 2025;203:35-40. PubMedAbstract available
HAMMOND S, Meng X, Barber J, Mosedale M, et al Tolvaptan safety in autosomal-dominant polycystic kidney disease; a focus on
idiosyncratic drug-induced liver injury liabilities.
Toxicol Sci. 2025;203:11-27. PubMedAbstract available
FAS L, Chen M, Tong W, Wenz F, et al Physiological liver microtissue 384-well microplate system for preclinical
hepatotoxicity assessment of therapeutic small molecule drugs.
Toxicol Sci. 2025;203:79-87. PubMedAbstract available
October 2024
KRAMER NE, Fillmore CE, Slane EG, Barnett LMA, et al Insights into brominated flame retardant neurotoxicity: mechanisms of hippocampal
neural cell death and brain region-specific transcriptomic shifts in mice.
Toxicol Sci. 2024;201:282-299. PubMedAbstract available
September 2024
ZHAO Y, Park JY, Yang D, Zhang M, et al A computational framework to in silico screen for drug-induced hepatocellular
toxicity.
Toxicol Sci. 2024;201:14-25. PubMedAbstract available
August 2024
CHO T, Hayes A, Henderson JT, Uetrecht J, et al The use of PD-1 functional knockout rats to study idiosyncratic adverse reactions
to nevirapine.
Toxicol Sci. 2024;200:382-393. PubMedAbstract available
BURON N, Porceddu M, Loyant R, Martel C, et al Drug-induced impairment of mitochondrial fatty acid oxidation and steatosis:
assessment of causal relationship with 45 pharmaceuticals.
Toxicol Sci. 2024;200:369-381. PubMedAbstract available
MEZENCEV R, Feshuk M, Kolaczkowski L, Peterson GC, et al The association between histopathologic effects and liver weight changes induced
in mice and rats by chemical exposures: an analysis of the data from Toxicity
Reference Database (ToxRefDB).
Toxicol Sci. 2024;200:404-413. PubMedAbstract available
June 2024
JEE A, Sernoskie SC, Uetrecht J The role of corticosterone in nevirapine-induced idiosyncratic drug-induced liver
injury.
Toxicol Sci. 2024;200:146-164. PubMedAbstract available
May 2024
SCULLION KM, MacIntyre IM, Sloan-Dennison S, Clark B, et al Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a
placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing
(PATH-BP biomarker substudy).
Toxicol Sci. 2024;199:203-209. PubMedAbstract available
March 2024
AKAKPO JY, Olivos H, Shrestha B, Midey A, et al Spatial analysis of renal acetaminophen metabolism and its modulation by
4-methylpyrazole with DESI mass spectrometry imaging.
Toxicol Sci. 2024;198:328-346. PubMedAbstract available
February 2024
TAKIMOTO N, Ishii Y, Mitsumoto T, Takasu S, et al Formation of hepatocyte cytoplasmic inclusions and their contribution to
methylcarbamate-induced hepatocarcinogenesis in F344 rats.
Toxicol Sci. 2024;198:40-49. PubMedAbstract available
XU C, Yan F, Zhao Y, Jaeschke H, et al Hepatocyte miR-21-5p-deficiency alleviates APAP-induced liver injury by inducing
PPARgamma and autophagy.
Toxicol Sci. 2024;198:50-60. PubMedAbstract available
O'SHAUGHNESSY KL, Sasser AL, Bell KS, Riutta C, et al Bypassing the brain barriers: upregulation of serum miR-495 and miR-543-3p
reflects thyroid-mediated developmental neurotoxicity in the rat.
Toxicol Sci. 2024;198:128-140. PubMedAbstract available
WIJAYA LS, Gabor A, Pot IE, van de Have L, et al A network-based transcriptomic landscape of HepG2 cells uncovering causal
gene-cytotoxicity interactions underlying drug-induced liver injury.
Toxicol Sci. 2024;198:14-30. PubMedAbstract available
December 2023
GHOSH P, Magee N, Akakpo JY, Ahamed F, et al Hepatocyte-specific deletion of small heterodimer partner protects mice against
acetaminophen-induced hepatotoxicity via activation of Nrf2.
Toxicol Sci. 2023;197:53-68. PubMedAbstract available
OGESE MO, Lister A, Farrell L, Gardner J, et al A blinded in vitro analysis of the intrinsic immunogenicity of hepatotoxic drugs:
implications for preclinical risk assessment.
Toxicol Sci. 2023;197:38-52. PubMedAbstract available
October 2023
RUSSOMANNO G, Sison-Young R, Livoti LA, Coghlan H, et al A systems approach reveals species differences in hepatic stress response
capacity.
Toxicol Sci. 2023;196:112-125. PubMedAbstract available
September 2023
FERGANY A, Zong C, Ekuban FA, Suzuki A, et al Deletion of IL-1beta exacerbates acrylamide-induced neurotoxicity in mice.
Toxicol Sci. 2023;195:246-256. PubMedAbstract available
July 2023
ZHUO X, Howell BA, Shen H, Woodhead JL, et al Mechanistic investigation of liver injury induced by BMS-932481, an experimental
É£-secretase modulator.
Toxicol Sci. 2023;194:235-245. PubMedAbstract available
March 2023
ALI SE, Waddington JC, Lister A, Sison-Young R, et al Identification of flucloxacillin-modified hepatocellular proteins: implications
in flucloxacillin-induced liver injury.
Toxicol Sci. 2023;192:106-116. PubMedAbstract available
MAASS C, Schaller S, Dallmann A, Bothe K, et al Considering developmental neurotoxicity in vitro data for human health risk
assessment using physiologically-based kinetic modeling: deltamethrin case study.
Toxicol Sci. 2023;192:59-70. PubMedAbstract available